Event ContactsPaid membership required to see this information
The highly anticipated marcus evans 2nd Annual Pharma Labeling Compliance Conference will deliver proven solutions to labeling compliance challenges in the pharmaceutical and biotechnology industries. By attending, global labeling and regulatory affairs professionals will discover techniques to create compliant labels and meet constantly evolving FDA regulations to ensure continued compliance.
2013 Participants Include:
AbbVie Inc., Actelion Pharmaceuticals, Allergan Inc., AstraZeneca, Biogen Idec, BioMarin Pharmaceutical Inc., Bristol-Myers Squibb, Celgene Corporation, Eisai, GlaxoSmithKline, Pfizer, Sanofi US, Vertex Pharmaceuticals, and many others!
Attendees will be afforded with the opportunity to benchmark their labeling practices against their peers in a classroom-style setting that encourages audience engagement and participation. Seating is limited to ensure an intimate educational environment and networking experience for all participants.
Don't wait to register for the 2nd Annual Pharma Labeling Compliance Conference. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||03/19/2014 - 03/20/2014|
|Conference/Event Hours:||8:00 AM - 5:00 PM|
|Other Industries:||Pharmaceutical, Professional Healthcare|
|Audience:||C-level executives, SVPs, VPs, Directors, and other senior-level executives in the pharmaceutical and biotechnology industries with responsibilities in:
- Global Labeling
- Global Labeling Operations
- Regulatory Affairs Labeling
- Labeling and Product Communications
- Global Regulatory Affairs
- Labeling Strategy
|Notes:||Capacity is limited at 50! Seating is on a first-come, first-serve basis.|
|Venue Type:||Indoor - Hotel|
|Booth Size||Booth Cost||Available Amenities|
|Call for details.||Electricity:||n/a|
|Marketing Vehicles Allowed:||Call|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.